BeiGene, a Hong Kong and Nasdaq-listed global, biotechnology company focused on developing affordable medicines, has priced an IPO on the Science and Technology Innovation Board (STAR Market) of the Shanghai…
BeiGene, a Hong Kong and Nasdaq-listed global, biotechnology company focused on developing affordable medicines, has priced an IPO on the Science and Technology Innovation Board (STAR Market) of the Shanghai…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference